文献速递腹部泌尿生殖CTMRUS

CT/MRI与CEUS LI-RADS主要特征与肝细胞癌关联的个体患者数据Meta分析

CT/MRI and CEUS LI-RADS Major Features Association with Hepatocellular Carcinoma: Individual Patient Data Meta-Analysis.
PubMed 文献 · Radiology · 2021-11-16

该系统评价与个体患者数据Meta分析纳入32项研究(CT观察1170个、MRI观察3341个、CEUS观察853个),评估高危患者中CT/MRI与CEUS LI-RADS各主要特征与肝细胞癌的独立关联。CT/MRI中非周边廓清(OR 13.2)与非环状动脉期高强化(OR 10.3)关联最强,阈值增长无关联(OR 1.6,P=0.07);CEUS中动脉期高强化、晚轻度廓清和≥20mm与HCC相关。

要点

  • CT/MRI LI-RADS中非周边廓清(OR 13.2)与非环状动脉期高强化(OR 10.3)与HCC关联最强。
  • CT/MRI LI-RADS中阈值增长与HCC无显著关联(OR 1.6,95%CI 0.7-3.6,P=0.07)。
  • CEUS LI-RADS中动脉期高强化、晚轻度廓清及≥20mm与HCC独立相关。

核心结论

  • 多数LI-RADS主要特征与HCC有不同强度的独立关联;CT/MRI中动脉期高强化和廓清关联最强,阈值增长无关联。

研究设计与样本

  • 系统评价与个体患者数据Meta分析,检索MEDLINE、Embase、Cochrane Central Register of Controlled Trials和Scopus 2014年1月至2019年9月文献,纳入32项研究(CT观察1170个、MRI观察3341个、CEUS观察853个),采用混合模型处理研究水平和患者水平聚类,多变量逐步logistic回归计算调整OR,QUADAS-2评估偏倚风险(PROSPERO注册号CRD42020164486)。

诊断标准与关键数值

  • CT/MRI LI-RADS:非周边廓清OR 13.2(95%CI 9.0-19.2,P=0.01),非环状动脉期高强化OR 10.3(95%CI 6.7-15.6,P=0.01),强化包膜OR 2.4(95%CI 1.7-3.5,P=0.03),阈值增长OR 1.6(95%CI 0.7-3.6,P=0.07)。
  • CEUS LI-RADS:动脉期高强化OR 7.3(95%CI 4.6-11.5,P=0.01),晚轻度廓清OR 4.1(95%CI 2.6-6.6,P=0.01),病灶大小≥20mm OR 1.6(95%CI 1.04-2.5,P=0.04)。

临床应用与阅片要点

  • CT/MRI LI-RADS中非周边廓清和非环状动脉期高强化对HCC的独立关联强于强化包膜,阈值增长未见独立关联。
  • CEUS LI-RADS中动脉期高强化、晚轻度廓清及病灶≥20mm与HCC独立相关。

局限性

  • 25项研究(78%)因报告模糊或研究设计缺陷存在高偏倚风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background The Liver Imaging Reporting and Data System (LI-RADS) assigns a risk category for hepatocellular carcinoma (HCC) to imaging observations. Establishing the contributions of major features can inform the diagnostic algorithm. Purpose To perform a systematic review and individual patient data meta-analysis to establish the probability of HCC for each LI-RADS major feature using CT/MRI and contrast-enhanced US (CEUS) LI-RADS in patients at high risk for HCC. Materials and Methods Multiple databases (MEDLINE, Embase, Cochrane Central Register of Controlled Trials, and Scopus) were searched for studies from January 2014 to September 2019 that evaluated the accuracy of CT, MRI, and CEUS for HCC detection using LI-RADS (CT/MRI LI-RADS, versions 2014, 2017, and 2018; CEUS LI-RADS, versions 2016 and 2017). Data were centralized. Clustering was addressed at the study and patient levels using mixed models. Adjusted odds ratios (ORs) with 95% CIs were determined for each major feature using multivariable stepwise logistic regression. Risk of bias was assessed using Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) (PROSPERO protocol: CRD42020164486). Results A total of 32 studies were included, with 1170 CT observations, 3341 MRI observations, and 853 CEUS observations. At multivariable analysis of CT/MRI LI-RADS, all major features were associated with HCC, except threshold growth (OR, 1.6; 95% CI: 0.7, 3.6; P = .07). Nonperipheral washout (OR, 13.2; 95% CI: 9.0, 19.2; P = .01) and nonrim arterial phase hyperenhancement (APHE) (OR, 10.3; 95% CI: 6.7, 15.6; P = .01) had stronger associations with HCC than enhancing capsule (OR, 2.4; 95% CI: 1.7, 3.5; P = .03). On CEUS images, APHE (OR, 7.3; 95% CI: 4.6, 11.5; P = .01), late and mild washout (OR, 4.1; 95% CI: 2.6, 6.6; P = .01), and size of at least 20 mm (OR, 1.6; 95% CI: 1.04, 2.5; P = .04) were associated with HCC. Twenty-five studies (78%) had high risk of bias due to reporting ambiguity or study design flaws. Conclusion Most Liver Imaging Reporting and Data System major features had different independent associations with hepatocellular carcinoma; for CT/MRI, arterial phase hyperenhancement and washout had the strongest associations, whereas threshold growth had no association. © RSNA, 2021 Online supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. van der Pol, McInnes, Salameh, et al. CT/MRI and CEUS LI-RADS Major Features Association with Hepatocellular Carcinoma: Individual Patient Data Meta-Analysis. Radiology. 2021. PMID: 34783596. doi:10.1148/radiol.2021211244

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。